NCT01604785View on ClinicalTrials.gov

Low-dose Propofol for Pediatric Migraine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Migraine Headache
Interventions
DRUG

Propofol

Sub-anesthetic dose propofol: 0.25 mg/kg IV push to maximum dose of 30mg q5 minutes to a maximum of 5 doses

DRUG

Standard Treatment

Ketorolac, Diphenhydramine and Metoclopramide

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT01604785 - Low-dose Propofol for Pediatric Migraine | Biotech Hunter | Biotech Hunter